These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29355651)

  • 21. One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS).
    Chan JCN; Gagliardino JJ; Ilkova H; Lavalle F; Ramachandran A; Mbanya JC; Shestakova M; Dessapt-Baradez C; Chantelot JM; Aschner P
    Adv Ther; 2021 Jun; 38(6):3281-3298. PubMed ID: 33978906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humanistic and economic burden of cardiovascular disease related comorbidities and hypoglycaemia among patients with type 2 diabetes in Japan.
    Terauchi Y; Ozaki A; Zhao X; Teoh C; Jaffe D; Tajima Y; Shuto Y
    Diabetes Res Clin Pract; 2019 Mar; 149():115-125. PubMed ID: 30685348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with Type 1 and insulin-treated Type 2 diabetes and problematic hypoglycaemia.
    Rondags SM; de Wit M; Snoek FJ
    Diabet Med; 2016 Feb; 33(2):184-91. PubMed ID: 26234919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey on 7289 patients from nine countries.
    Emral R; Pathan F; Cortés CAY; El-Hefnawy MH; Goh SY; Gómez AM; Murphy A; Abusnana S; Rudijanto A; Jain A; Ma Z; Mirasol R;
    Diabetes Res Clin Pract; 2017 Dec; 134():17-28. PubMed ID: 28951336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with Type 1 and insulin-treated Type 2 diabetes mellitus.
    Khunti K; Cigrovski Berković M; Ludvik B; Moberg E; Barner Lekdorf J; Gydesen H; Pedersen-Bjergaard U
    Diabet Med; 2018 May; 35(9):1232-41. PubMed ID: 29729048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization.
    Dalal MR; Kazemi M; Ye F; Xie L
    Adv Ther; 2017 Sep; 34(9):2083-2092. PubMed ID: 28779282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool.
    Parekh WA; Ashley D; Chubb B; Gillies H; Evans M
    Diabet Med; 2015 Sep; 32(9):1156-66. PubMed ID: 25816891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
    Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
    Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians.
    Brod M; Rana A; Barnett AH
    Curr Med Res Opin; 2012 Dec; 28(12):1947-58. PubMed ID: 23150950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study.
    Aronson R; Goldenberg R; Boras D; Skovgaard R; Bajaj H
    Can J Diabetes; 2018 Feb; 42(1):11-17. PubMed ID: 28528246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the cost-utility of insulin degludec vs insulin glargine in Sweden.
    Ericsson Å; Pollock RF; Hunt B; Valentine WJ
    J Med Econ; 2013 Dec; 16(12):1442-52. PubMed ID: 24147661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
    Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
    BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study.
    de Valk HW; Feher M; Hansen TK; Jendle J; Koefoed MM; Rizi EP; Zimmermann E; Fadini GP
    Diabetes Ther; 2020 Sep; 11(9):2159-2167. PubMed ID: 32666165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of insulin detemir compared with NPH insulin in people with type 2 diabetes in Denmark, Finland, Norway, and Sweden.
    Ridderstråle M; Jensen MM; Gjesing RP; Niskanen L
    J Med Econ; 2013; 16(4):468-78. PubMed ID: 23384160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of non-severe hypoglycemic events on work productivity and diabetes management.
    Brod M; Christensen T; Thomsen TL; Bushnell DM
    Value Health; 2011; 14(5):665-71. PubMed ID: 21839404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of managing severe hypoglycaemia in three European countries.
    Hammer M; Lammert M; Mejías SM; Kern W; Frier BM
    J Med Econ; 2009; 12(4):281-90. PubMed ID: 20001570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.